drugset
drugset / Trial / NCT05409157

A Study to Evaluate the Drug Levels of BMS-986166 in Healthy Male Participants

NCT05409157 ↗

Phase 1 Completed 7 enrolled Bristol-Myers Squibb
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the drug levels of BMS-986166 in healthy male participants.

Timeline

Start
2022-06-17
Primary completion
2022-10-15
Completion
2022-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject BMS-986166 Small molecule — —
Background Bisacodyl Small molecule — —

Indications

No indication recorded.